214 related articles for article (PubMed ID: 8638341)
1. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Gebuhr PH; Wilbek H; Soelberg M
Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
[TBL] [Abstract][Full Text] [Related]
2. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
Gebuhr P; Wilbek H; Soelberg M
Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
[TBL] [Abstract][Full Text] [Related]
3. Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients.
Gebuhr P; Soelberg M; Orsnes T; Wilbek H
Acta Orthop Scand; 1991 Jun; 62(3):226-9. PubMed ID: 1904183
[TBL] [Abstract][Full Text] [Related]
4. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of naproxen prophylaxis for the prevention of heterotopic ossification after hip surgery: a meta-analysis.
Ma R; Chen GH; Zhao LJ; Zhai XC
J Orthop Surg Res; 2018 Mar; 13(1):48. PubMed ID: 29506541
[TBL] [Abstract][Full Text] [Related]
6. Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty.
Pellegrini VD; Gregoritch SJ
J Bone Joint Surg Am; 1996 Jun; 78(6):870-81. PubMed ID: 8666605
[TBL] [Abstract][Full Text] [Related]
7. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.
Pellegrini VD; Konski AA; Gastel JA; Rubin P; Evarts CM
J Bone Joint Surg Am; 1992 Feb; 74(2):186-200. PubMed ID: 1541613
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
Nilsson OS
Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
[TBL] [Abstract][Full Text] [Related]
9. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty.
Ayers DC; Evarts CM; Parkinson JR
J Bone Joint Surg Am; 1986 Dec; 68(9):1423-30. PubMed ID: 3097023
[TBL] [Abstract][Full Text] [Related]
10. Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
Sodemann B; Persson PE; Nilsson OS
Clin Orthop Relat Res; 1988 Dec; (237):158-63. PubMed ID: 3142716
[TBL] [Abstract][Full Text] [Related]
11. Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial.
Beckmann JT; Wylie JD; Potter MQ; Maak TG; Greene TH; Aoki SK
J Bone Joint Surg Am; 2015 Dec; 97(24):2032-7. PubMed ID: 26677237
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial.
Nayak KN; Mulliken B; Rorabeck CH; Bourne RB; Woolfrey MR
Can J Surg; 1997 Oct; 40(5):368-74. PubMed ID: 9336527
[TBL] [Abstract][Full Text] [Related]
13. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report.
Kjaersgaard-Andersen P; Ritter MA
Clin Orthop Relat Res; 1992 Jun; (279):157-62. PubMed ID: 1600651
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
[TBL] [Abstract][Full Text] [Related]
15. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
16. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
17. The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.
Beckmann JT; Wylie JD; Kapron AL; Hanson JA; Maak TG; Aoki SK
Am J Sports Med; 2014 Jun; 42(6):1359-64. PubMed ID: 24664136
[TBL] [Abstract][Full Text] [Related]
18. The use of cobalt therapy to prevent heterotopic ossification after total hip arthroplasty.
Sudanese A; Tabarroni M; Busanelli L; Testoni M; Toni A; Spagnolli MF; Fanton F; Brizio L; Giunti A
Chir Organi Mov; 1996; 81(2):89-106. PubMed ID: 8968113
[TBL] [Abstract][Full Text] [Related]
19. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.
Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ
J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094
[TBL] [Abstract][Full Text] [Related]
20. Ketorolac prophylaxis against heterotopic ossification after hip replacement.
Pritchett JW
Clin Orthop Relat Res; 1995 May; (314):162-5. PubMed ID: 7634630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
